Stay updated on Sitravatinib Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Sitravatinib Combo in Advanced NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

- Check19 days agoChange DetectedThe government funding status notice on the page was removed, eliminating the related warning about updates and operation status.SummaryDifference0.4%

- Check34 days agoChange DetectedResults First Posted 2025-04-17 and a sponsor-initiated termination notice based on data from other trials are now shown on the study page.SummaryDifference0.4%

- Check62 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference2%

- Check69 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedMinor update: version increased from v3.0.1 to v3.0.2 and the 'Back to Top' link/button was removed; no impact on core content or critical data.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.